Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation

Matthias M. Weber, Christoph J. Auernhammer, Phillip Lee, Dieter Engelhardt, Reinhart Zachoval

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Introduction: The liver is the main source of serum insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) and the concentration of these proteins might reflect liver function. Methods: In a retrospective longitudinal study we examined serum levels of total and free IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 in 21 adult patients with end-stage liver disease before and after orthotopic liver transplantation (LTX) by sensitive and specific RIAs. In each patient, the mean value of at least three measurements before and after LTX was calculated. Results: Before LTX, serum levels of total and free IGF-I, IGF-II, IGFBP-3 were low and showed a rapid and significant increase in almost all patients after successful LTX (total IGF-I: 30±7 vs. 256±30 ng/ml, p< 0.001; free IGF-I: 1.3±0.3 vs. 3.5±0.6 ng/ml, p<0.01; IGF-II: 177±28 vs. 618±30 ng/ml, p<0.001; IGFBP-3: 1,230±136 vs. 3,665±264 ng/ml, p<0.001). In contrast, IGFBP-1 was found to be high immediately before LTX, and declined to normal levels after LTX (210±40 vs. 90±15 ng/ml, p<0.01), while IGFBP-2 did not show any significant changes (1,154±296 vs. 1,303±192 ng/ml). Positive correlations were found between IGF-I, IGF-II or IGFBP-3, and serum pseudocholinesterase (R = 0.50, 0.72 and 0.61 respectively, p<0.001). Negative correlations were found between IGF-I, IGF-II or IGFBP-3, and prothrombin time (R = 0.50, 0.59 and 0.51 respectively, p<0.001). Conclusion: Patients with severe liver disease show decreased levels of total and free IGF-I, IGF-II and IGFBP-3, and increased levels of IGFBP-1. These abnormalities are promptly normalized after successful LTX. Thus, serum levels of IGF-I, IGF-II and IGFBP-3 might be useful parameters for the assessment of liver function.

Original languageEnglish (US)
Pages (from-to)105-112
Number of pages8
JournalHormone Research
Volume57
Issue number3-4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor Binding Protein 3
Somatomedins
Insulin-Like Growth Factor II
Insulin-Like Growth Factor I
Liver Transplantation
Liver Diseases
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 2
Serum
Liver
Insulin-Like Growth Factor Binding Protein 6
Pseudocholinesterase
End Stage Liver Disease
Prothrombin Time
Longitudinal Studies
Retrospective Studies

Keywords

  • Binding proteins
  • IGF
  • Insulin-like growth factors
  • Liver disease
  • Liver function
  • Liver transplantation

ASJC Scopus subject areas

  • Endocrinology

Cite this

Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. / Weber, Matthias M.; Auernhammer, Christoph J.; Lee, Phillip; Engelhardt, Dieter; Zachoval, Reinhart.

In: Hormone Research, Vol. 57, No. 3-4, 2002, p. 105-112.

Research output: Contribution to journalArticle

Weber, Matthias M. ; Auernhammer, Christoph J. ; Lee, Phillip ; Engelhardt, Dieter ; Zachoval, Reinhart. / Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. In: Hormone Research. 2002 ; Vol. 57, No. 3-4. pp. 105-112.
@article{7a6c0c0142ad412f87213b2692511566,
title = "Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation",
abstract = "Introduction: The liver is the main source of serum insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) and the concentration of these proteins might reflect liver function. Methods: In a retrospective longitudinal study we examined serum levels of total and free IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 in 21 adult patients with end-stage liver disease before and after orthotopic liver transplantation (LTX) by sensitive and specific RIAs. In each patient, the mean value of at least three measurements before and after LTX was calculated. Results: Before LTX, serum levels of total and free IGF-I, IGF-II, IGFBP-3 were low and showed a rapid and significant increase in almost all patients after successful LTX (total IGF-I: 30±7 vs. 256±30 ng/ml, p< 0.001; free IGF-I: 1.3±0.3 vs. 3.5±0.6 ng/ml, p<0.01; IGF-II: 177±28 vs. 618±30 ng/ml, p<0.001; IGFBP-3: 1,230±136 vs. 3,665±264 ng/ml, p<0.001). In contrast, IGFBP-1 was found to be high immediately before LTX, and declined to normal levels after LTX (210±40 vs. 90±15 ng/ml, p<0.01), while IGFBP-2 did not show any significant changes (1,154±296 vs. 1,303±192 ng/ml). Positive correlations were found between IGF-I, IGF-II or IGFBP-3, and serum pseudocholinesterase (R = 0.50, 0.72 and 0.61 respectively, p<0.001). Negative correlations were found between IGF-I, IGF-II or IGFBP-3, and prothrombin time (R = 0.50, 0.59 and 0.51 respectively, p<0.001). Conclusion: Patients with severe liver disease show decreased levels of total and free IGF-I, IGF-II and IGFBP-3, and increased levels of IGFBP-1. These abnormalities are promptly normalized after successful LTX. Thus, serum levels of IGF-I, IGF-II and IGFBP-3 might be useful parameters for the assessment of liver function.",
keywords = "Binding proteins, IGF, Insulin-like growth factors, Liver disease, Liver function, Liver transplantation",
author = "Weber, {Matthias M.} and Auernhammer, {Christoph J.} and Phillip Lee and Dieter Engelhardt and Reinhart Zachoval",
year = "2002",
doi = "10.1159/000057960",
language = "English (US)",
volume = "57",
pages = "105--112",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation

AU - Weber, Matthias M.

AU - Auernhammer, Christoph J.

AU - Lee, Phillip

AU - Engelhardt, Dieter

AU - Zachoval, Reinhart

PY - 2002

Y1 - 2002

N2 - Introduction: The liver is the main source of serum insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) and the concentration of these proteins might reflect liver function. Methods: In a retrospective longitudinal study we examined serum levels of total and free IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 in 21 adult patients with end-stage liver disease before and after orthotopic liver transplantation (LTX) by sensitive and specific RIAs. In each patient, the mean value of at least three measurements before and after LTX was calculated. Results: Before LTX, serum levels of total and free IGF-I, IGF-II, IGFBP-3 were low and showed a rapid and significant increase in almost all patients after successful LTX (total IGF-I: 30±7 vs. 256±30 ng/ml, p< 0.001; free IGF-I: 1.3±0.3 vs. 3.5±0.6 ng/ml, p<0.01; IGF-II: 177±28 vs. 618±30 ng/ml, p<0.001; IGFBP-3: 1,230±136 vs. 3,665±264 ng/ml, p<0.001). In contrast, IGFBP-1 was found to be high immediately before LTX, and declined to normal levels after LTX (210±40 vs. 90±15 ng/ml, p<0.01), while IGFBP-2 did not show any significant changes (1,154±296 vs. 1,303±192 ng/ml). Positive correlations were found between IGF-I, IGF-II or IGFBP-3, and serum pseudocholinesterase (R = 0.50, 0.72 and 0.61 respectively, p<0.001). Negative correlations were found between IGF-I, IGF-II or IGFBP-3, and prothrombin time (R = 0.50, 0.59 and 0.51 respectively, p<0.001). Conclusion: Patients with severe liver disease show decreased levels of total and free IGF-I, IGF-II and IGFBP-3, and increased levels of IGFBP-1. These abnormalities are promptly normalized after successful LTX. Thus, serum levels of IGF-I, IGF-II and IGFBP-3 might be useful parameters for the assessment of liver function.

AB - Introduction: The liver is the main source of serum insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) and the concentration of these proteins might reflect liver function. Methods: In a retrospective longitudinal study we examined serum levels of total and free IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3 and IGFBP-6 in 21 adult patients with end-stage liver disease before and after orthotopic liver transplantation (LTX) by sensitive and specific RIAs. In each patient, the mean value of at least three measurements before and after LTX was calculated. Results: Before LTX, serum levels of total and free IGF-I, IGF-II, IGFBP-3 were low and showed a rapid and significant increase in almost all patients after successful LTX (total IGF-I: 30±7 vs. 256±30 ng/ml, p< 0.001; free IGF-I: 1.3±0.3 vs. 3.5±0.6 ng/ml, p<0.01; IGF-II: 177±28 vs. 618±30 ng/ml, p<0.001; IGFBP-3: 1,230±136 vs. 3,665±264 ng/ml, p<0.001). In contrast, IGFBP-1 was found to be high immediately before LTX, and declined to normal levels after LTX (210±40 vs. 90±15 ng/ml, p<0.01), while IGFBP-2 did not show any significant changes (1,154±296 vs. 1,303±192 ng/ml). Positive correlations were found between IGF-I, IGF-II or IGFBP-3, and serum pseudocholinesterase (R = 0.50, 0.72 and 0.61 respectively, p<0.001). Negative correlations were found between IGF-I, IGF-II or IGFBP-3, and prothrombin time (R = 0.50, 0.59 and 0.51 respectively, p<0.001). Conclusion: Patients with severe liver disease show decreased levels of total and free IGF-I, IGF-II and IGFBP-3, and increased levels of IGFBP-1. These abnormalities are promptly normalized after successful LTX. Thus, serum levels of IGF-I, IGF-II and IGFBP-3 might be useful parameters for the assessment of liver function.

KW - Binding proteins

KW - IGF

KW - Insulin-like growth factors

KW - Liver disease

KW - Liver function

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=0036249955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036249955&partnerID=8YFLogxK

U2 - 10.1159/000057960

DO - 10.1159/000057960

M3 - Article

VL - 57

SP - 105

EP - 112

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 3-4

ER -